These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 26614745)
1. IL-10-producing regulatory B cells are decreased in patients with psoriasis. Hayashi M; Yanaba K; Umezawa Y; Yoshihara Y; Kikuchi S; Ishiuji Y; Saeki H; Nakagawa H J Dermatol Sci; 2016 Feb; 81(2):93-100. PubMed ID: 26614745 [TBL] [Abstract][Full Text] [Related]
2. Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid. Kabuto M; Fujimoto N; Takahashi T; Tanaka T Br J Dermatol; 2017 May; 176(5):1204-1212. PubMed ID: 27716906 [TBL] [Abstract][Full Text] [Related]
3. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis. Yang B; Tan X; Xiong X; Wu D; Zhang G; Wang M; Dong S; Liu W; Yang H; Li Q Immunol Res; 2017 Jun; 65(3):592-604. PubMed ID: 27837410 [TBL] [Abstract][Full Text] [Related]
4. CD70-mediated CD27 expression downregulation contributed to the regulatory B10 cell impairment in rheumatoid arthritis. Shi L; Hu F; Zhu L; Xu C; Zhu H; Li Y; Liu H; Li C; Liu N; Xu L; Mu R; Li Z Mol Immunol; 2020 Mar; 119():92-100. PubMed ID: 32006824 [TBL] [Abstract][Full Text] [Related]
5. Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides. Akatsuka T; Miyagaki T; Nakajima R; Kamijo H; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S Eur J Dermatol; 2018 Jun; 28(3):314-319. PubMed ID: 29952298 [TBL] [Abstract][Full Text] [Related]
6. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder. Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658 [TBL] [Abstract][Full Text] [Related]
7. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls. Kristensen B Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805 [TBL] [Abstract][Full Text] [Related]
8. Decrease in the proportion of CD24 Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037 [TBL] [Abstract][Full Text] [Related]
9. Purification and Immunophenotypic Characterization of Human CD19 Bradford HF; Mauri C Methods Mol Biol; 2021; 2270():77-90. PubMed ID: 33479894 [TBL] [Abstract][Full Text] [Related]
10. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies. Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of regulatory B10 cells in patients with rheumatoid arthritis with different disease status. Zheng Z; Li X; Li X; Ding J; Feng Y; Miao J; Luo X; Wu Z; Zhu P Mol Med Rep; 2015 Sep; 12(3):4584-4591. PubMed ID: 26081876 [TBL] [Abstract][Full Text] [Related]
12. Characterization of CD19 Gu Y; Li K; Sun J; Zhang J J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2863-2870. PubMed ID: 32242984 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19 Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24 Körber N; Pohl L; Weinberger B; Grubeck-Loebenstein B; Wawer A; Knolle PA; Roggendorf H; Protzer U; Bauer T Front Immunol; 2021; 12():713351. PubMed ID: 34566969 [TBL] [Abstract][Full Text] [Related]
15. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis. Mavropoulos A; Zafiriou E; Simopoulou T; Brotis AG; Liaskos C; Roussaki-Schulze A; Katsiari CG; Bogdanos DP; Sakkas LI Rheumatology (Oxford); 2019 Dec; 58(12):2240-2250. PubMed ID: 31209492 [TBL] [Abstract][Full Text] [Related]
16. Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. Yanaba K; Kamata M; Ishiura N; Shibata S; Asano Y; Tada Y; Sugaya M; Kadono T; Tedder TF; Sato S J Leukoc Biol; 2013 Oct; 94(4):563-73. PubMed ID: 23630391 [TBL] [Abstract][Full Text] [Related]
17. IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNγ-producing T cells. Mavropoulos A; Varna A; Zafiriou E; Liaskos C; Alexiou I; Roussaki-Schulze A; Vlychou M; Katsiari C; Bogdanos DP; Sakkas LI Clin Immunol; 2017 Nov; 184():33-41. PubMed ID: 28461105 [TBL] [Abstract][Full Text] [Related]
18. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis. Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800 [TBL] [Abstract][Full Text] [Related]
20. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis. Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]